Clinical Trials

Pharmaxis has conducted a number of clinical trials as part of the regulatory approvals process for Bronchitol.

Cystic Fibrosis

Phase III
Description CF303: Treatment of adults with Cystic Fibrosis
Sites 120 Sites in Europe , Australia, Middle East, New Zealand, North America, Russia, South Africa, South America
Subjects 350-440
Status In progress
More Information

NCT02134353*

Media Releases

ClinicalTrials.gov is a service provided by the U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine. ClinicalTrials.gov provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions. Pharmaxis chooses to publish all Pivotal Trials on the ClinicalTrials.gov website.

** Pubmed is a service of the U.S. National Library of Medicine and the National Institutes of Health.

*** No further clinical development planned in Bronchiectasis